Screening of anti-obesity drugs, their analogues and prohibited ingredients in slimming foods |
Yun, Jisuk
(New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Choi, Jangduck (New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Kwon, Kisung (New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Jo, Cheon-Ho (New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) |
1 | Lee YC, Kim BS, Yun ES, Kim SD, Chang MS, Park YA, Shin Y, Jung SO, Lee JI, Chae YZ. Monitoring of forbidden medicines as adulterants in dietary supplements marketed online by HPLC and ESI-tandom mass spectrometry. Korean J. Food Sci. Technol. 44: 148-154 (2012) DOI |
2 | Jang YM, Kim SY, Chang HS, Jang IH, Kim JI, Kim KH, Lee JH, Jung YK, Park J, Jeong D, Won S, Lee H, Shin D, Shin S, Lee JY, Kim ES, Kim OS, Lim MS, Hu SJ, Chae KR, Park SY, Kim EJ, Joo HJ, Lee JS, Han YJ, Cho JH, Lee HY. Monitoring and Elucidation of Novel Illegal Compounds in Foods about Compounds relative to Erectile Dysfunction Drugs and It's Analogues, Steroid Ingredients, and etc. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 56-57 (2013) |
3 | Jang YM, Choi J, Chang HS, Kim JI, Yun J, Kim KH, Lee JH, Jung YK, Park J, Jeong D, Cho WJ, Won S, Kim J, Shin D, Lee H, Kim KW, Choi SO, Park MH, Lim MS, Kang N, Kim I, Shin J, Kim M, Cho JH, Lee JJ. Monitoring and Elucidation of Novel Illegal Compounds in Foods-about Compounds relative to Erectile Dysfunction Drugs and Their Analogues, Steroids, etc. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 215 (2014) |
4 | Kwon K, Choi J, Jo CH, Yun J, Lee JH, Kang TS, Lee JH, Jung YK, Kim W, Kim JI, Shin D, Kim T, Won S, Park H, Cho WJ, Kim J, Choi SO, Chung SY, Chai JY, Oh MH, Cho JH, Lim MS, Kim EJ, Kim S, Kim E. Monitoring and Elucidation of Novel Illegal Compounds in Foods-with a Focus on Anti-impotence Drugs, Anti-obesity Drugs and Their Analogues. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 244-246 (2015) |
5 | Luque CA, Rey JA. The discovery and status of sibutramine as an anti-obesity drug. Eur. J. Pharmacol. 440: 119-129 (2002) DOI |
6 | Food and Drug Administration. Memorandum to the file NDA 20-632 Meridia (sibutramine hydrochloride monohydrate). Available from: http://www.fda.gov/downloads/drugs/drugsafety/ucm228795.pdf. Accessed May 25, 2016. |
7 | Ministry of Food and Drug Safety. Food Sanitation Law. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 23-35 (2015) |
8 | Ministry of Food and Drug Safety. Food Code -Analytical Method II-. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 1262-1281 (2015) |
9 | Choi D, Choi J, Park SK, Suh J, Ju S, Yoon T, Kim E, Han S . Safety Evaluation of Illegal Compounds in Food. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 7-20 (2008) |
10 | Ministry of Food and Drug Safety. Food & Drug Statistical Yearbook. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 51-52 (2015) |
11 | Association of Official Analytical Chemists. Appendix K: Guidelines for dietary supplements and botanicals. Available from: http://www.aoac.org/aoac_prod_imis/AOAC_Docs/StandardsDevelopment/ eoma_appendix_k.pdf. Accessed May 20, 2016. |
12 | Mans DJ, Gucinski AC, Dunn JD, Gryniewicz-Ruzicka CM, Mecker-Pogue LC, Kao J L-F, Ge X. Rapid screening and structural elucidation of a novel sibutramine analogue in a weight loss supplement: 11-Desisobutyl-11-benzylsibutramine. J. Pharm. Biomed. Anal. 83: 122-128 (2013) DOI |
13 | Zeng Y, Xu Yimin, Kee CL, Low MY, Ge X. Analysis of 40 weight loss compounds adulterated in health supplements by liquid chromatography quadrupole linear ion trap mass spectrometry. Drug Test. Analysis 8: 351-356 (2016) DOI |
14 | Kim HJ, Lee JH, Park HJ, Cho SH, Cho S, Kim WS. Monitoring of 29 weight loss compounds in foods and dietary supplements by LC-MS/MS. Food Addit. Contam. A 31: 777-783 (2014) DOI |
15 | Tam SW, Worcel M, Wyllie M. Yohimbine: a clinical review. Parm. Therapeu. 91: 215-243 (2001) DOI |
16 | McCarty MF. Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysis. Med. Hypotheses 58: 491-495 (2002) DOI |
17 | Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: A retrospective review of the California poison control system reported cases. Ann. Pharmacother. 44: 1022-1029 (2010) DOI |
18 | Corazza O, Martinotti G, Santacroce R, Chillemi E, Di Giannantonio M, Schifano F, Cellek S. Sexual enhancement products for sale online: Raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginko biloba. Biomed. Res. Int. 2014: 841798 (2014) |